These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 9832353)
1. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. Normann C; Brandt C; Berger M; Walden J Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353 [TBL] [Abstract][Full Text] [Related]
2. [Persistent cerebellar syndrome after treatment with lithium and a neuroleptic]. Merle C; Sotto A; Galland MC; Jourdan E; Jourdan J Therapie; 1998; 53(5):511-3. PubMed ID: 9921050 [No Abstract] [Full Text] [Related]
3. [Delirium syndrome as a side-effect of lithium in normal lithium levels]. Niethammer R; Keller A; Weisbrod M Psychiatr Prax; 2000 Sep; 27(6):296-7. PubMed ID: 11050737 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome. Yasugi S; Garg V; Been G; Magoulas P Aust N Z J Psychiatry; 2010 Jun; 44(6):584. PubMed ID: 20482421 [No Abstract] [Full Text] [Related]
5. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
6. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Nasrallah HA; Brecher M; Paulsson B Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884 [TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia in a neuroleptic-naive patient with bipolar-I disorder: persistent exacerbation after lithium intoxication. Meyer-Lindenberg A; Krausnick B Mov Disord; 1997 Nov; 12(6):1108-9. PubMed ID: 9399254 [No Abstract] [Full Text] [Related]
9. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of bipolar disorders]. Schmauss M; Messer T MMW Fortschr Med; 2009 Mar; 151(13):74-8. PubMed ID: 19504825 [No Abstract] [Full Text] [Related]
11. [Valproate induced hypoactive delirium in a bipolar disorder patient with psychotic features]. Ozen S; Bülbül I; Soyuçok E Turk Psikiyatri Derg; 2010; 21(1):79-84. PubMed ID: 20204907 [TBL] [Abstract][Full Text] [Related]
12. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics. Reischies FM; Hartikainen J; Berghöfer AM Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274 [TBL] [Abstract][Full Text] [Related]
13. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes. Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604 [TBL] [Abstract][Full Text] [Related]
14. Clinical decision making in the treatment of mania. Perlis RH J Clin Psychiatry; 2008; 69 Suppl 5():16-21. PubMed ID: 19265636 [TBL] [Abstract][Full Text] [Related]
15. Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance. Prescrire Int; 2001 Aug; 10(54):113-5. PubMed ID: 11718180 [TBL] [Abstract][Full Text] [Related]
16. Decision model for the acute treatment of mania. Steffens DC; Krishnan KR Depress Anxiety; 1996-1997; 4(6):289-93. PubMed ID: 9166657 [TBL] [Abstract][Full Text] [Related]
17. Reversible oro-lingual dyskinesia related to lithium intoxication. Chen WY; Chen AC; Tsai SJ; Lin JJ Acta Neurol Taiwan; 2013 Mar; 22(1):32-5. PubMed ID: 23479244 [TBL] [Abstract][Full Text] [Related]
18. Lithium-neuroleptic neurotoxicity in the elderly bipolar patient. Miller F; Menninger J; Whitcup SM J Clin Psychopharmacol; 1986 Jun; 6(3):176-8. PubMed ID: 2872237 [TBL] [Abstract][Full Text] [Related]